Pharmaceutical industry – Page 14
-
-
BusinessTissue scaffolds from resin inks
4D Medicine’s biodegradable polymer inks can be 3D-printed into useful biomedical applications
-
OpinionWhen should employees share profits from inventions?
Glucose monitor inventor wins £2m payout from Unilever after claiming his work provided ’outstanding benefit’
-
BusinessPharmaceuticals roundup 2019
Under the shadow of political turmoil and major lawsuits, the industry returned to its strengths – making new drugs, and finding new ways to do it better
-
BusinessChemicals industry roundup 2019
Focus turns to sustainability amid rising economic pressures and political uncertainty
-
PodcastOxycodone and hydrocodone
Frances Addison examines how our quest to control and manage pain has led to a modern medical crisis, as opioids oxycodone and hydrocodone are among the most abused prescription medications in the US
-
-
ArticlePharma and healthcare meets data and digitalisation
UK-based company Life Science Integrates exists to facilitate collaboration between digital, pharma and life sciences industries – helping form partnerships that revolutionise healthcare
-
ArticleCultivating innovation in the UK’s life science industry
Scientific and digital collaboration is key to maintaining the UK’s esteemed status in global life sciences and pharma circles. CPI exists to facilitate and underpin those vital relationships
-
ArticleArtificial intelligence: on the cusp of a digital revolution
AI is transforming the pharma industry and its drug discovery pipeline
-
ArticleIon mobility spectrometry: the future of pharma analysis
Ion mobility spectrometry is transforming the field of biomolecule research, with Waters technology at the forefront of this vital analytical innovation
-
-
OpinionWill computers ever discover drugs from scratch?
With enough understanding and computing power, it should be possible, but will it happen?
-
BusinessFormer Ranbaxy owners arrested for fraud
Singh brothers accused of misappropriation, as well as not paying previous fines relating to Ranbaxy’s takeover by Daiichi Sankyo
-
BusinessThe rise of venture philanthropy
More and more charities are investing in companies, and looking for returns on that investment, as an alternative to traditional grants
-
BusinessNitrosamine contamination withdrawals spread to new drugs
After ranitidine recalls, EU regulators instruct companies to review all their products for potential impurities
-
BusinessSixth in a line of Alzheimer’s drugs fails in trials
Treatments designed to stop amyloid peptide formation all seem to cause cognitive impairment rather than prevent it
-
ArticleThe importance of solid form science in modern drug development
A recent study suggests that around 40% of drugs with market approval exhibit poor water solubility and although this is not a new problem, solutions like those offered by Johnson Matthey are still relevant to today’s pharma market
-
OpinionIs bankruptcy best for Purdue?
Many would prefer to see the Sackler family held personally liable, and the company wound down
-
BusinessChemical firms urged to plan for no-deal Brexit
European Chemicals Agency highlights hundreds of chemicals whose Reach registrations would be voided